CERO logo
CERO NASDAQ US

CERo Therapeutics Holdings, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Oct 2021
$0.03
▼ $0.00 (-2.86%)
Vol 258K
1
Quality Score
fail
Mkt Cap
$1.4M
ROE
-4.8%
D/E
214.03
Beta
0.34
52W
$0–$205

Wall Street Consensus

7 analysts · Apr 2026
0
Strong Buy
0
Buy
4
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Earnings

Beat rate: 50.0%
Quarter EPS Est EPS Act Surprise
Sep 2025 $-0.90 $-3.44 $-2.54
Mar 2025 $-121.58 $-28.80 +$92.78

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -4.8% -4.8% -4.8% -4.8% -4.8%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 214.03 214.03 214.03 214.03 214.03
Current Ratio 0.56 0.73 0.56 0.56 0.56 0.56

Key Ratios

ROA (TTM)
-209.4%
EPS (TTM)
$-75.01
52W High
$205.00
52W Low
$0.05
$0.05 52-Week Range $205.00

How does CERO compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

CERO AAPG ABEO ABOS ABP

CERO valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

CERO profitability vs Biotechnology peers

ROE
-4.8%
93% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-209.4%
348% below peers (-46.7%)
vs Peers
vs Industry
Weak

CERO financial health vs Biotechnology peers

D/E ratio
214.0
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
0.6
87% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
65% below peers (1.0)
vs Peers
vs Industry
More volatile

CERO fundamentals radar

CERO Peer median Industry

CERO profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

CERO vs peers: key metrics

Latest News

No related news yet